Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
(NQ: )
N/A   UNCHANGED
Last Price  /  Updated:   /  Add to My Watchlist      
View: Quote News
Press releases about
 
< Previous 1 2 3 4 5 Next >
DUSA Pharmaceuticals Reports First Quarter 2009 Corporate Highlights and Financial Results
May 12, 2009
Q1 Domestic PDT Revenues up 21% Year Over Year; BLU-U(R) Unit Sales up 45% Read More
from Marketwired News Releases
DUSA Initiates Clinical Trial of Levulan(R) PDT on High-Risk Solid Organ Transplant Recipients
May 11, 2009
Study Will Investigate the Safety and Efficacy of Levulan(R) Photodynamic Therapy for the Treatment of Actinic Keratoses and the Prevention of Skin Cancer Recurrence Read More
from Marketwired News Releases
DUSA Pharmaceuticals, Inc. Announces First Quarter Financial Results and Corporate Highlights Conference Call
May 06, 2009
from Marketwired News Releases
DUSA Hits the Road With The Skin Cancer Foundation to Raise Awareness of Skin Cancer
May 05, 2009
The Road to Healthy Skin Tour Provides Free Skin Exams Across the U.S. Read More
from Marketwired News Releases
DUSA Pharmaceuticals Reports Fourth Quarter and Full Year 2008 Corporate Highlights and Financial Results
March 11, 2009
Domestic Levulan(R) Kerastick(R) Revenues Up 29% for the Quarter and 34% for the Year; Non-GAAP Full Year Net Loss Improves by 44% Despite the Loss of Nicomide(R) Revenues Read More
from Marketwired News Releases
DUSA Pharmaceuticals, Inc.(R) to Host Fourth Quarter and Full Year 2008 Financial Results and Corporate Highlights Conference Call
March 06, 2009
from Marketwired News Releases
DUSA Pharmaceuticals to Present at the 11th Annual BIO CEO & Investor Conference
February 04, 2009
from Marketwired News Releases
DUSA Elects Alexander Casdin to Board of Directors
January 29, 2009
from Marketwired News Releases
DUSA Pharmaceuticals to Present at the Rodman & Renshaw 10th Annual Healthcare Conference
November 04, 2008
from Marketwired News Releases
DUSA Pharmaceuticals Reports Third Quarter 2008 Corporate Highlights and Financial Results
November 03, 2008
Q3 Levulan(R) Kerastick(R) Revenues up 54% year over year; Read More
from Marketwired News Releases
DUSA Pharmaceuticals, Inc. Announces Third Quarter Financial Results and Corporate Highlights Conference Call
October 27, 2008
from Marketwired News Releases
DUSA Announces Results for Phase IIB Trial Of Levulan(R) Photodynamic Therapy for Moderate to Severe Acne
October 22, 2008
A conference call will be held today, Wednesday, October 22, 5:00 p.m. E.D.T. Read More
from Marketwired News Releases
DUSA Announces Patent Licensing Agreement
August 14, 2008
from Marketwired News Releases
DUSA Pharmaceuticals to Present at the Noble Financial Equity Conference
August 12, 2008
from Marketwired News Releases
DUSA Pharmaceuticals Reports Second Quarter 2008 Corporate Highlights and Financial Results
August 08, 2008
Q2 Levulan(R) Kerastick(R) Revenues up 39% year over year; Q2 Non-GAAP loss improves 88% year over year to ($0.2) million Read More
from Marketwired News Releases
DUSA Pharmaceuticals, Inc. Announces Revised Schedule for Second Quarter Financial Results and Corporate Highlights Conference Call
August 04, 2008
from Marketwired News Releases
DUSA Pharmaceuticals, Inc. to Host Second Quarter Financial Results and Corporate Highlights Conference Call
July 31, 2008
from Marketwired News Releases
BeaconEquity.com Issues Technical Trade Alerts on Healthcare/Pharmaceutical Stocks: DUSA, MBRK, NOVA, ADLR, AFFX, ABAX
July 25, 2008
from PR Newswire
DUSA Announces Update on Nicomide(R) Status
July 18, 2008
from Marketwired News Releases
DUSA Pharmaceuticals to Present at the Jefferies 2nd Annual Healthcare Conference on June 26
June 19, 2008
from Marketwired News Releases
DUSA Files Form S-3 Shelf Registration Statement
May 16, 2008
from Marketwired News Releases
DUSA Pharmaceuticals Reports First Quarter 2008 Corporate Highlights and Financial Results
May 07, 2008
Q1 Levulan(R) Kerastick(R) unit sales up 36% year over year; Read More
from Marketwired News Releases
DUSA Pharmaceuticals, Inc. to Host First Quarter Financial Results and Corporate Highlights Conference Call
May 02, 2008
from Marketwired News Releases
Phase I Clinical Trial of Photodynamic Therapy (PDT) Underway for Potential New Treatment of Oral Precancerous Lesions
May 01, 2008
DUSA Pharmaceuticals, Inc.(R) collaborates with the National Cancer Institute to evaluate Levulan(R) (aminolevulinic acid, ALA) PDT as treatment for oral leukoplakia Read More
from Marketwired News Releases
DUSA Pharmaceuticals Chairman Role Expected to Change Due to Serious Illness
April 21, 2008
from Marketwired News Releases
DUSA Completes Enrollment for Phase IIb Trial of Levulan(R) Photodynamic Therapy for Moderate to Severe Acne
March 31, 2008
from Marketwired News Releases
DUSA Announces Stiefel's Receipt of Pricing Approval of Levulan PDT in Brazil
March 06, 2008
Commercial Launch to Follow Read More
from Marketwired News Releases
DUSA Pharmaceuticals Reports Fourth Quarter and Full Year 2007 Corporate Highlights and Financial Results
March 04, 2008
Q4 Levulan(R) Kerastick(R) unit sales up 33% year over year, Read More
from Marketwired News Releases
DUSA Pharmaceuticals, Inc. to Host Fourth Quarter and Full Year 2007 Corporate Highlights and Financial Results Conference Call
February 28, 2008
from Marketwired News Releases
DUSA Pharmaceuticals to Present at Roth Capital Partners 20th Annual Growth Stock Conference
February 13, 2008
from Marketwired News Releases
< Previous 1 2 3 4 5 Next >
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here